Graft vs Host Disease  >>  cyclosporine  >>  Phase 3
Welcome,         Profile    Billing    Logout  

7 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cyclosporine / Generic mfg.
NCT00002456: Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation

Completed
3
US
cyclosporine, methotrexate, allogeneic bone marrow transplantation
Fred Hutchinson Cancer Center
Graft Versus Host Disease, Leukemia, Lymphoma
 
04/02
NCT00003414: Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease

Completed
3
50
US
aldesleukin, recombinant interferon gamma, busulfan, cyclophosphamide, cyclosporine, peripheral blood stem cell transplantation, radiation therapy
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, National Cancer Institute (NCI)
Graft Versus Host Disease, Lymphoma
05/04
05/04
NCT00031824: Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease

Completed
3
82
US, Canada, Europe, RoW
cyclosporine, hydroxychloroquine, prednisone, tacrolimus
Children's Oncology Group, National Cancer Institute (NCI)
Graft Versus Host Disease
05/05
01/11
NCT00195273: Study Evaluating Sirolimus in Kidney Transplant Recipients

Completed
3
61
Europe
sirolimus, cyclosporine, mycophenolate mofetil, corticosteroids, daclizumab
Wyeth is now a wholly owned subsidiary of Pfizer
Graft vs Host Disease, Kidney Transplantation
07/08
07/08
NCT00298324 / 2005-006178-86: Myfortic - Treatment for Extensive cGvHD

Terminated
3
34
Europe, RoW
Myfortic, Prednisone and Cyclosporine
European Society for Blood and Marrow Transplantation, Novartis
Graft vs Host Disease
11/09
11/10
NCT00993343: Randomized Trial Comparing Sirolimus and Tacrolimus Versus Cyclosporine and Methotrexate as Graft-versus-host Disease (GVHD) Prophylaxis After Allogeneic Stem Cell Transplantation

Completed
3
215
Europe
Sirolimus/tacrolimus, cyclosporine/methotrexate
Karolinska Institutet
Graft-versus-host Disease, Survival
02/15
04/15
NCT01788501: Tacrolimus/Methotrexate Versus Cyclosporine/Methotrexate for Prophylaxis of Graft Versus Host Disease

Completed
2/3
50
RoW
Tacrolimus, Cyclosporine, Methotrexate
Seoul National University Hospital
Graft vs Host Disease
03/17
03/17

Download Options